Full menu

Closing Announcement

PDF doesn't open in Chrome

2018 Closing Announcement of FY2018
03.22.2019

8th ClosingAnnouncement.png
 

2017 Closing Announcement of FY2017
03.22.2018

2017 Closing Announcement of FY2017
 

2016 Closing Announcement of FY2016
10.27.2017

2016 Closing Announcement of FY2016

Closing Announcement of FY2016

As of December 31, 2016

(Unit KRW)

Closing Announcement of FY2016 - Account, Amount
Account Amount Account Amount
ASSETS LIABILITIES
CURRENT ASSETS 1,461,425,176,461 CURRENT LIABILITIES 2,476,545,193,419
Cash and cash equivalents 230,337,600,616 Trade and other payables 138,056,375,073
Short-term financial instruments 970,000,000,000 Financial liabilities at fair value through profit or loss 1,874,470,943,472
Trade and other receivables 75,630,820,228 Current financial liabilities 403,694,084,360
Inventories 164,219,979,645 Other current liabilities 60,323,790,514
Other financial assets 16,289,300,000
Other current assets 4,947,475,972 NON-CURRENT LIABILITIES 974,091,453,352
Long-term trade and other payables 2,300,379,825
Long-term borrowings 439,363,194,458
Defined benefit obligations 5,757,265,062
Deferred tax liabilities 526,670,614,007
TOTAL LIABILITIES 3,450,636,646,771
NON-CURRENT ASSETS 6,071,590,929,883 SHAREHOLDERS' EQUITY
Long-term financial instruments 8,000,000 Share capital 165,412,500,000
Investments in associates & joint ventures 4,944,356,289,991 Capital surplus 2,487,313,082,024
Property, plant and equipment 1,090,959,765,965 Accumulated other comprehensive income(loss) 4,947,004,536
Intangible assets 14,044,654,106 Retained earnings 1,424,706,873,013
Other financial assets 21,475,000,000
Other non-current assets 747,219,821 TOTAL SHAREHOLDERS' EQUITY 4,082,379,459,573
TOTAL ASSETS 7,533,016,106,344 TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY 7,533,016,106,344

March 24, 2017

SAMSUNG BIOLOGICS CO., LTD.

PRESIDENT & CEO Tae Han Kim

The financial statements present fairly, in all material respects, the financial position of the company as of December 31, 2016 and its financial performance and its cash flows for the years ended December 31, 2016 in accordance with K-IFRS.

Deloitte Anjin LLC CEO Jong Ho Ham